(Total Views: 709)
Posted On: 05/16/2024 11:59:32 PM
Post# of 155600
Quote:
Keytruda's my guess.
From the mouse trial down in Texas, Merck must know by now that leronlimab has the same effect as Keytruda and blows past it on other aspects of tumor suppression. Of course if there's no standalone leronlimab arm they can cover it up and say "Leronlimab combined with Keytruda and SOC is superior to standard of care".
(15)
(0)
